Yuan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuan Wang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Jeremy L. Jenkins
Novartis Biomedical Research, Cambridge, MA, USA
3 shared publications - Bosco Leung
Cell Biology Program, The Hospital for Sick Children, Toronto, Canada
2 shared publications - Larry Wasserman
Department of Statistics & Data Science Machine Learning Department Carnegie Mellon University
2 shared publications - Marc Hild
Novartis Institutes for Biomedical Research, Cambridge, USA
2 shared publications - Marc W. Kirschner
Department of Systems Biology, Harvard Medical School
2 shared publications - Miriam Bracha Ginzberg
The Hospital for Sick Children, Canada
2 shared publications
Latest Publications
- 8 May 2018
- Published by Springer Nature
- Vol. 1787, 195-206
Quantitative Prioritization of Tool Compounds for Phenotypic Screening
Phenotypic screens are increasingly utilized in drug discovery for multiple purposes such as lead and/or tool compound finding, and target discovery. Using potent and selective chemical tool compounds against well-defined targets in phenotypic screens can help elucidate biological processes modulating assay phenotypes. Unfortunately the identification of such tools from large heterogeneous bioactivity databases is nontrivial and there is repeated use of published unselective compounds as phenotypic tools. Here we describe a computational model, the compound-target tool score (TS), which is an evidence-based quantitative confidence metric that can be used to systematically rank tool compounds for targets. The identified selective and nonselective tool compounds have applications in phenotypic assays for target hypothesis validation as well as assay development.
- 8 May 2018
- Published by Springer Nature
- Vol. 1787, 195-206
Quantitative Prioritization of Tool Compounds for Phenotypic Screening
Phenotypic screens are increasingly utilized in drug discovery for multiple purposes such as lead and/or tool compound finding, and target discovery. Using potent and selective chemical tool compounds against well-defined targets in phenotypic screens can help elucidate biological processes modulating assay phenotypes. Unfortunately the identification of such tools from large heterogeneous bioactivity databases is nontrivial and there is repeated use of published unselective compounds as phenotypic tools. Here we describe a computational model, the compound-target tool score (TS), which is an evidence-based quantitative confidence metric that can be used to systematically rank tool compounds for targets. The identified selective and nonselective tool compounds have applications in phenotypic assays for target hypothesis validation as well as assay development.
- Open Access
- 29 March 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Size uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length
Animal cells within a tissue typically display a striking regularity in their size. To date, the molecular mechanisms that control this uniformity are still unknown. We have previously shown that size uniformity in animal cells is promoted, in part, by size-dependent regulation of G1 length. To identify the molecular mechanisms underlying this process, we performed a large-scale small molecule screen and found that the p38 MAPK pathway is involved in coordinating cell size and cell cycle progression. Small cells display higher p38 activity and spend more time in G1 than larger cells. Inhibition of p38 MAPK leads to loss of the compensatory G1 length extension in small cells, resulting in faster proliferation, smaller cell size and increased size heterogeneity. We propose a model wherein the p38 pathway responds to changes in cell size and regulates G1 exit accordingly, to increase cell size uniformity.
- 29 March 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Open AccessSize uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length
Animal cells within a tissue typically display a striking regularity in their size. To date, the molecular mechanisms that control this uniformity are still unknown. We have previously shown that size uniformity in animal cells is promoted, in part, by size-dependent regulation of G1 length. To identify the molecular mechanisms underlying this process, we performed a large-scale small molecule screen and found that the p38 MAPK pathway is involved in coordinating cell size and cell cycle progression. Small cells display higher p38 activity and spend more time in G1 than larger cells. Inhibition of p38 MAPK leads to loss of the compensatory G1 length extension in small cells, resulting in faster proliferation, smaller cell size and increased size heterogeneity. We propose a model wherein the p38 pathway responds to changes in cell size and regulates G1 exit accordingly, to increase cell size uniformity.
- Open Access
Size uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length
Animal cells within a tissue typically display a striking regularity in their size. To date, the molecular mechanisms that control this uniformity are still unknown. We have previously shown that size uniformity in animal cells is promoted, in part, by size-dependent regulation of G1 length. To identify the molecular mechanisms underlying this process, we performed a large-scale small molecule screen and found that the p38 MAPK pathway is involved in coordinating cell size and cell cycle progression. Small cells display higher p38 activity and spend more time in G1 than larger cells. Inhibition of p38 MAPK leads to loss of the compensatory G1 length extension in small cells, resulting in faster proliferation, smaller cell size and increased size heterogeneity. We propose a model wherein the p38 pathway responds to changes in cell size and regulates G1 exit accordingly, to increase cell size uniformity. One-sentence summary: The p38 MAP kinase pathway coordinates cell growth and cell cycle progression by lengthening G1 in small cells, allowing them more time to grow before their next division.
Open AccessSize uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length
Animal cells within a tissue typically display a striking regularity in their size. To date, the molecular mechanisms that control this uniformity are still unknown. We have previously shown that size uniformity in animal cells is promoted, in part, by size-dependent regulation of G1 length. To identify the molecular mechanisms underlying this process, we performed a large-scale small molecule screen and found that the p38 MAPK pathway is involved in coordinating cell size and cell cycle progression. Small cells display higher p38 activity and spend more time in G1 than larger cells. Inhibition of p38 MAPK leads to loss of the compensatory G1 length extension in small cells, resulting in faster proliferation, smaller cell size and increased size heterogeneity. We propose a model wherein the p38 pathway responds to changes in cell size and regulates G1 exit accordingly, to increase cell size uniformity. One-sentence summary: The p38 MAP kinase pathway coordinates cell growth and cell cycle progression by lengthening G1 in small cells, allowing them more time to grow before their next division.
- 1 July 2016
- Published by Elsevier in Cell Chemical Biology
- Vol. 23 (7) , 862-874
Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery
- 1 July 2016
- Published by Elsevier in Cell Chemical Biology
- Vol. 23 (7) , 862-874
Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery